182 related articles for article (PubMed ID: 33123999)
1. Androgen Signaling in the Tumor Microenvironment.
Özdemir BC
Adv Exp Med Biol; 2021; 1270():169-183. PubMed ID: 33123999
[TBL] [Abstract][Full Text] [Related]
2. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor moonlighting in the prostate cancer microenvironment.
Cioni B; Zwart W; Bergman AM
Endocr Relat Cancer; 2018 Jun; 25(6):R331-R349. PubMed ID: 29618577
[TBL] [Abstract][Full Text] [Related]
4. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract][Full Text] [Related]
5. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
6. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.
Niu Y; Chang TM; Yeh S; Ma WL; Wang YZ; Chang C
Oncogene; 2010 Jun; 29(25):3593-604. PubMed ID: 20440270
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.
Liao CP; Chen LY; Luethy A; Kim Y; Kani K; MacLeod AR; Gross ME
Endocr Relat Cancer; 2017 Apr; 24(4):157-170. PubMed ID: 28264911
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
Chen R; Yu Y; Dong X
J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
[TBL] [Abstract][Full Text] [Related]
9. Stromal androgen receptor in prostate development and cancer.
Singh M; Jha R; Melamed J; Shapiro E; Hayward SW; Lee P
Am J Pathol; 2014 Oct; 184(10):2598-607. PubMed ID: 25088980
[TBL] [Abstract][Full Text] [Related]
10. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.
Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B
J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620
[TBL] [Abstract][Full Text] [Related]
11. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.
Ricke EA; Williams K; Lee YF; Couto S; Wang Y; Hayward SW; Cunha GR; Ricke WA
Carcinogenesis; 2012 Jul; 33(7):1391-8. PubMed ID: 22535887
[TBL] [Abstract][Full Text] [Related]
12. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
[TBL] [Abstract][Full Text] [Related]
14. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
[TBL] [Abstract][Full Text] [Related]
15. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
16. Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion.
Li Y; Li CX; Ye H; Chen F; Melamed J; Peng Y; Liu J; Wang Z; Tsou HC; Wei J; Walden P; Garabedian MJ; Lee P
J Cell Mol Med; 2008 Dec; 12(6B):2790-8. PubMed ID: 18266956
[TBL] [Abstract][Full Text] [Related]
17. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.
Gerdes MJ; Dang TD; Larsen M; Rowley DR
Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509
[TBL] [Abstract][Full Text] [Related]
19. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
[TBL] [Abstract][Full Text] [Related]
20. Androgen axis in prostate cancer.
Culig Z; Bartsch G
J Cell Biochem; 2006 Oct; 99(2):373-81. PubMed ID: 16598769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
